Pilot clinical trial in China to test University of British Columbia researcher’s findings as a targeted therapy for COVID-19
APN01, developed based on the work of UBC’s Josef Penninger, already shown to block viral spread in SARS A University of British Columbia researcher is part of an international team working with a biotechnology company on a pilot clinical trial of a potential new treatment for patients with severe coronavirus infections in Guangzhou, China. Dr.